Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Executive Deputy EditorIndividualAuthor
To the Editor: Dr D'Amico and colleagues1 reported that patients at intermediate and high
risk of prostate-specific antigen (PSA) failure had better PSA outcomes if
they were treated with radiation therapy (RT) and androgen suppression therapy
(AST) vs RT alone. However, there are several serious problems with this study
that limit its validity.
Vicini FA, Kestin L, Martinez A. Biochemical Outcomes of Treatment for Prostate Cancer. JAMA. 2000;284(22):2869. doi:10.1001/jama.284.22.2869